Lambros Zellos M.D.
- Clinical Co-Director of the International Mesothelioma Program
- Brigham and Women’s Hospital
Lambros Zellos not only has a Medical Degree but a Masters in Public Health degree. He received his Bachelors of Science in Biology in May 1990 from the University of Maryland College Park. He continued his medical education at Georgetown University School of Medicine in Washington D.C. in 1994. He received his Masters in Public Health from Harvard School of Public Health in 2001. From 1994 to 1995 he was a General Surgery Intern at Georgetown University Medical Center and from 1995 to 1996 was a General Surgery Resident there. Dr. Zellos became a Research Fellow in the Division of Cardiac Surgery in West Roxbury, Virginia and the Brigham and Women’s Hospital at Harvard Medical School in Boston, Massachusetts from 1996 to 1997. From there he went back to Georgetown University Medical Center where he was a General Surgery Resident from 1997 until 1999 and became Chief Resident of General Surgery from 1999 to 2000. From 2000 to 2002 Dr. Zellos completed a Thoracic Surgery Oncology Fellowship in the Division of Thoracic Surgery at Brigham and Women’s Hospital and was a Thoracic Surgery Resident there from 2002 to 2004. He also was the Staff Surgeon at Brigham & Women’s Hospital and the Dana Farber Cancer Institute from 2004 to 2008. And he worked as the Clinical Co-Director of International Mesothelioma Program at Brigham & Women’s Hospital from 2004-2007. Currently, he is an instructor of Surgery at Harvard medical School. Zellos has many certifications including his most recent certificate from the American Board of Thoracic Surgery in 2005. He also holds many honors and awards including membership to many Honor Societies, the Marguerite George Resident Award for Excellence in Vascular Surgery and the John J. Collins Cardiothoracic Surgeon Scholar Award.
Like many mesothelioma doctors, Dr. Zellos is a proponent of the trimodality approach. This includes either a pleurectomy/decortication or an extrapleural pneumonectomy with chemotherapy and radiation therapy after. However, Dr. Zellos prefers to treat with the extrapleural pneumonectomy because it allows more radiation to be delivered to the cancerous cells after surgery. He advocates the extrapleural pneumonectomy to perform a complete macroscopic cytoreduction and proposes that a routine pericardlectomy is important for this procedure. Dr. Zellos has also studied the affects of using intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection of malignant pleural mesothelioma. However, the study was found inconclusive at best.
- Brigham and Women’s Hospital. Physician Profile.
Last modified: December 24, 2010.